Skip to main content

How worried should we be about the omicron variant?

 How worried should we be about the omicron variant?

When any new variant of the virus that causes Covid-19 is identified, we don’t at first know how infectious it will be; whether it will cause a more serious illness than other variants; and how well vaccines will work against it. We therefore need to be cautious and take measures to control the spread of Omicron until this information becomes available. We shouldn’t however become unduly anxious.

I’ve heard that the variant causes more mild symptoms. Is that true and if so why are we worried?

Some early reports from South Africa suggest that Omicron may cause a milder illness than other variants. However, we will need data from many more people infected with the Omicron variant – particularly, older and clinically vulnerable people – before we can reach reliable conclusions about the severity of the illness it causes.

Why are they giving more booster jabs if the new variant can evade existing vaccines?

Two doses of current vaccines provide good protection – and three doses provides event better protection - against the other strains of coronavirus. At present, we have no evidence that the Omicron variant can evade existing vaccines. We need to continue with the booster programme as this has been very effective in keeping down the number of serious infections that can result in hospital admission or death.

Does the new variant transmit any differently?

We don’t yet have good data on whether Omicron can infect people more easily than other variants. This data will gradually emerge in the coming weeks.

Does it mean existing Covid treatments like the new antiviral treatments won’t work either?

It is possible that some of the newer antiviral treatments won’t work as well against Omicron as against other variants. However, this will need to be confirmed in research studies. It’s very likely however that antiviral treatments will still reduce the severity of illness caused by Omicron.

What don’t we know about omicron and when will we know?

We currently lack important information about Omicron – such as how infectious it is; whether it causes a more severe illness than other variants; how well vaccines protect against it; and whether antiviral drugs will be helpful in reducing the severity of illness it causes. Research is already underway to answer these questions.

How likely is it to affect Christmas and how?

We currently have a high Covid-19 infection rate in the UK. Fortunately, vaccines are keeping down the number of people with a more severe illness, which in turn is keeping the number of hospital admissions and deaths low. If we can get a high uptake of boosters in adults, we should be able to have a more normal Christmas this year. But everyone should continue with good infection control measures and not rely just on vaccination. People who are not vaccinated at all (around 11% of people aged 12 and over in the UK) should also come forwards for vaccination.

Will wearing masks really stop it?

Masks can reduce the spread of infection – particularly if a higher specification FFP2 mask is worn. When combined with other infection control measures such as vaccination and home working, masks can help reduce the spread of infection.

Will bringing forward boosters mean they’re not as efficient?

Brining forward the booster to three months instead of six months after people’s second vaccination won’t reduce its effectiveness in preventing serious illness. The booster dose substantially increases people’s immunity and this can help stop the Omicron variant evading our current vaccines.

What will happen in schools?

Many schools in England have had large Covid-19 outbreaks since September when the new school year started. It’s important that 12-15 year old children are vaccinated and also get a second vaccination once the government has approved this. People working in schools also need to be fully vaccinated with three doses (four doses for people with weak immune systems). Any child who is unwell with symptoms of a possible Covid-19 infection should get a PCR test and isolate until the result is back. Improving ventilation and air quality in schools is also essential to reduce the risk of infection.

Could there be more travel bans?

If the Omicron variant spreads further, then more countries may be placed on the government’s Red List. This can happen with very little notice, leaving travellers with the option of either cutting short their trip and returning quickly to the UK; or facing an expensive stay in a quarantine hotel. Everyone should consider this if they are planning an overseas trip in the next few weeks.

A version of this article was first published in the Daily Mirror.

Comments

Popular posts from this blog

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...

Talking to Patients About Weight-Loss Drugs

The use of weight-loss drugs such as GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) has increased rapidly in recent years. These drugs can help some people achieve significant weight reduction, but they are not suitable for everyone and require careful counselling before starting treatment. By discussing benefits, risks, practicalities, and  uncertainties, clinicians can help patients make informed, realistic decisions about their treatment. Key points to discuss with patients 1. Indications and eligibility These drugs are usually licensed for adults with a specific BMI. They should be used alongside lifestyle interventions such as dietary change, increased physical activity, and behaviour modification. 2. Potential side effects – some can be serious Common adverse effects include nausea, vomiting, diarrhoea, and abdominal discomfort. Less common but more serious risks include gallstones, pancreatitis and visual problems. Patients should know what to watch for a...

Abolishing NHS England will make only modest savings

Abolishing NHS England and reducing Integrated Care Board (ICB) staffing by 50% may appear substantial, but the projected savings - around £500 million annually if fully achieved - would represent only a modest increase (approximately 0.25%) in annual NHS funding in England, given the NHS England budget is approaching £200 billion per year. Evidence from past NHS reforms (like the 2012 Health and Social Care Act) shows mixed results; some efficiency gains but often offset by new layers of complexity elsewhere in NHS structures. Without parallel initiatives to streamline administrative processes, improve efficiency, and enhance clinical productivity, such structural changes to NHS England and ICBs alone will not significantly improve frontline clinical care or health outcomes. Administrative costs, while important to minimise, make up a relatively small proportion of the overall NHS budget. Genuine productivity gains will therefore require systematic reforms aimed at reducing unnecessar...